Atrys is a global healthtech company that provides medical services that maximise efficiency in prevention, diagnosis and precision medical treatment through innovative technologies. It is a pioneer in telemedicine and oncology treatment. It has a team of more than 2,400 professionals, is present in seven countries in Europe and Latin America, and is the only listed company in the healthcare technology sector in Spain.
The company structures its activity around two main business areas. On one side, precision medicine, which includes diagnostics (telemedicine, nuclear medicine, pathology and molecular anatomy) and oncology treatment (medical oncology and advanced radiotherapy); and on the other, preventive medicine, dedicated to prevention and health promotion, which serves more than one million people through its network of more than 200 branches.
The management team consists of scientists and senior managers with a solid career in the field of health. In total, Atrys has now 30 professionals specializing in oncology.
De Torres Sanahuja, Santiago - Executive President
Lozano Fernández, Isabel - CEO
Huch Ginesta, José María - CFO
Giró, Antonio - Managing Director Diagnostics
Isach, Marian Isach - Managing Director Oncology
Sánchez, Sara - Managing Director Prevention
Within the diagnostics business other than in the area of oncology, Atrys uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology and dermatology, using its own technology platform. This activity benefits Atrys's business relationship with stakeholders in the health sector, in a simmilar manner as in the field of oncology.
Precision Medicine
Preventive Medicine
Occupational Medicine
Smart Data
Diagnostic Tests
Diagnostic Imaging
Telemedicine
Medical and Radiation Oncology
Clinical trials
Training
R&D projects
Research conducted by the team of Atrys in collaboration with international medical centers of academic excellence has produced results indicating that Single Dose high intensity radiation treatments allow to activate different biological mechanisms for tumor cure that are not activated with conventional radiotherapy.
The company model includes a molecular diagnostic methodology for individual tumor phenotyping that generates information that allows the specialist to identify which clinical approach is more appropriate for each patient and, in particular, to identify those who can benefit from the single-dose stereotactic body radiation therapy (SD-SBRT or Single dose radiotherapy).
Atrys is born with the mission to help people live healthier lives with a prolonged life expectancy.
To do this, it seeks to facilitate access to medical diagnosis and treatments of excellence, overcoming physical location barriers between doctor and patient specialist.
Atrys y la Universidad de Barcelona reconocen la innovación en la terapia contra el cáncer en la tercera edición de los ‘Premios de Investigación en Radioterapia Personalizada’
Atrys Health
Atrys ingresa 107,4 millones de euros y su EBITDA ajustado alcanza 25,3 millones de euros en el primer semestre del año
Atrys Health
Atrys y la Universidad de Barcelona lanzan la III edición de los Premios de la Cátedra UB Atrys de Radioterapia Personalizada
Atrys Health
Atrys Health fortalece la colaboración con el sector público para impulsar los servicios de diagnóstico y medicina de prevención
Atrys Health
Atrys logra unos ingresos de 51,4 millones de euros y mejora su EBITDA ajustado en un 17,2% en el primer trimestre del año 2024
Atrys Health
Atrys Health incrementa un 27,3% sus ingresos que ascienden a 202 millones de euros en el 2023
Atrys Health
Atrys Health y el Hospital Viamed Santa Elena se alían para el tratamiento del cáncer con un nuevo servicio en Oncología Médica
Atrys Health
Atrys alcanza un acuerdo para la venta de su área de negocio de compliance
Atrys Health
Atrys alcanza un acuerdo con Arraigo para la venta de Conversia, su área de negocio de compliance
Atrys Health
Atrys, pionera en la aplicación de un nuevo fármaco en cáncer de próstata en Portugal
Atrys Health
